Crystec is delighted to be attending DDL 2024 (Drug Delivery to the Lungs) on its 35-year anniversary at Edinburgh International Conference Centre, from December 11th to December 13th.
DDL 2024 is bringing together professionals from a variety of fields involved in the development of medicines for inhalation. To arrange a meeting with Crystec CEO Paul Thorning at DDL 2024, please get in touch at: wendy.towler@crytecpharma.com Visit: https://ddl-conference.com/ to learn more about DDL 2024.
